| Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints ME Mikucki, DT Fisher, J Matsuzaki, JJ Skitzki, NB Gaulin, JB Muhitch, ... Nature communications 6 (1), 7458, 2015 | 454 | 2015 |
| Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, MR Albertini, C Barker, WE Carson, C Contreras, ... Journal of the National Comprehensive Cancer Network 17 (4), 367-402, 2019 | 377 | 2019 |
| Hyperthermia as an immunotherapy strategy for cancer JJ Skitzki, EA Repasky, SS Evans Current opinion in investigational drugs (London, England: 2000) 10 (6), 550, 2009 | 263 | 2009 |
| Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, A Algazi, R Andtbacka, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 14 (4), 450-473, 2016 | 250 | 2016 |
| IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells DT Fisher, Q Chen, JJ Skitzki, JB Muhitch, L Zhou, MM Appenheimer, ... The Journal of clinical investigation 121 (10), 3846-3859, 2011 | 245 | 2011 |
| Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in … K Turaga, E Levine, R Barone, R Sticca, N Petrelli, L Lambert, G Nash, ... Annals of surgical oncology 21, 1501-1505, 2014 | 233 | 2014 |
| NCCN Guidelines® insights: melanoma: cutaneous, version 2.2021: featured updates to the NCCN guidelines SM Swetter, JA Thompson, MR Albertini, CA Barker, J Baumgartner, ... Journal of the National Comprehensive Cancer Network 19 (4), 364-376, 2021 | 197 | 2021 |
| Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist LG Burdelya, CM Brackett, B Kojouharov, II Gitlin, KI Leonova, ... Proceedings of the National Academy of Sciences 110 (20), E1857-E1866, 2013 | 134 | 2013 |
| Managing metastatic melanoma in 2022: a clinical review B Switzer, I Puzanov, JJ Skitzki, L Hamad, MS Ernstoff JCO oncology practice 18 (5), 335-351, 2022 | 127 | 2022 |
| Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): the Roswell Park experience and a review of the literature A Jarkowski III, R Hare, P Loud, JJ Skitzki, JM Kane III, KS May, ... American journal of clinical oncology 39 (6), 545-548, 2016 | 127 | 2016 |
| The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms Annals of surgical oncology 27 (6), 1753-1760, 2020 | 109* | 2020 |
| NCCN guidelines insights: melanoma, version 3.2016 DG Coit, JA Thompson, A Algazi, R Andtbacka, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 14 (8), 945-958, 2016 | 105 | 2016 |
| Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes AW Ku, JB Muhitch, CA Powers, M Diehl, M Kim, DT Fisher, AP Sharda, ... Elife 5, e17375, 2016 | 104 | 2016 |
| Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy DT Fisher, Q Chen, MM Appenheimer, J Skitzki, WC Wang, K Odunsi, ... Immunological investigations 35 (3-4), 251-277, 2006 | 84 | 2006 |
| Intraoperative intravital microscopy permits the study of human tumour vessels DT Fisher, JB Muhitch, M Kim, KC Doyen, PN Bogner, SS Evans, ... Nature communications 7 (1), 10684, 2016 | 82 | 2016 |
| Intratumoral IL-12 and TNF-α–loaded microspheres lead to regression of breast cancer and systemic antitumor immunity MS Sabel, J Skitzki, L Stoolman, NK Egilmez, E Mathiowitz, N Bailey, ... Annals of surgical oncology 11, 147-156, 2004 | 80 | 2004 |
| Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern Q Li, AL Carr, EJ Donald, JJ Skitzki, R Okuyama, LM Stoolman, AE Chang Cancer research 65 (3), 1063-1070, 2005 | 79 | 2005 |
| Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials JJ Skitzki, AE Chang Surgical oncology 11 (3), 123-135, 2002 | 71 | 2002 |
| A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion M Haslinger, V Francescutti, K Attwood, JA McCart, M Fakih, JM Kane III, ... Cancer medicine 2 (3), 334-342, 2013 | 65 | 2013 |
| Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons AH Maciver, E Al-Sukhni, J Esquivel, JJ Skitzki, JM Kane, VA Francescutti Annals of surgical oncology 24, 923-930, 2017 | 55 | 2017 |
